NEWS ALERT SIGNUP STAY IN TOUCH HOME OUR COMPANY PRODUCT PORTFOLIO INVESTORS PRESS RELEASES CAREERS CONTACT Investors relations contact Our head office Hyloris Pharmaceuticals SA HQ: Boulevard Gustave Kleyer 17, 4000 Liège, Belgium T: +32 (0)4 346 02 07 E: investorrelations@hyloris.com Find us on Linkedin Contact form Country* Aruba Afghanistan Angola Albania Andorra United Arab Emirates Argentina Armenia American Samoa Antigua and Barbuda Australia Austria Azerbaijan Burundi Belgium Benin Burkina Faso Bangladesh Bulgaria Bahrain Bahamas Bosnia and Herzegovina Belarus Belize Bermuda Bolivia, Plurinational State of Brazil Barbados Brunei Darussalam Bhutan Botswana Central African Republic Canada Switzerland Chile China Côte d’Ivoire Cameroon Congo, the Democratic Republic of the Congo Cook Islands Colombia Comoros Cape Verde Costa Rica Cuba Cayman Islands Cyprus Czech Republic Germany Djibouti Dominica Denmark Dominican Republic Algeria Ecuador Egypt Eritrea Spain Estonia Ethiopia Finland Fiji France Micronesia, Federated States of Gabon United Kingdom Georgia Ghana Guinea Gambia Guinea-Bissau Equatorial Guinea Greece Grenada Guatemala Guam Guyana Hong Kong Honduras Croatia Haiti Hungary Indonesia India Ireland Iran, Islamic Republic of Iraq Iceland Israel Italy Jamaica Jordan Japan Kazakhstan Kenya Kyrgyzstan Cambodia Kiribati Saint Kitts and Nevis Korea, Republic of Kuwait Lao People’s Democratic Republic Lebanon Liberia Libya Saint Lucia Liechtenstein Sri Lanka Lesotho Lithuania Luxembourg Latvia Morocco Monaco Moldova, Republic of Madagascar Maldives Mexico Marshall Islands Macedonia, the former Yugoslav Republic of Mali Malta Myanmar Montenegro Mongolia Mozambique Mauritania Mauritius Malawi Malaysia Namibia Niger Nigeria Nicaragua Netherlands Norway Nepal Nauru New Zealand Oman Pakistan Panama Peru Philippines Palau Papua New Guinea Poland Puerto Rico Korea, Democratic People’s Republic of Portugal Paraguay Palestine, State of Qatar Romania Russian Federation Rwanda Saudi Arabia Sudan Senegal Singapore Solomon Islands Sierra Leone El Salvador San Marino Somalia Serbia Sao Tome and Principe Suriname Slovakia Slovenia Sweden Swaziland Seychelles Syrian Arab Republic Chad Togo Thailand Tajikistan Turkmenistan Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Taiwan, Province of China Tanzania, United Republic of Uganda Ukraine Uruguay United States Uzbekistan Saint Vincent and the Grenadines Venezuela, Bolivarian Republic of Virgin Islands, U.S. Viet Nam Vanuatu Samoa Yemen South Africa Zambia Zimbabwe SUBMIT Hyloris Pharmaceuticals SA HQ: Boulevard Gustave Kleyer 17, 4000 Liège, Belgium T:+32 (0)4 346 02 07 E:contact@hyloris.com Quick links HOME INVESTORS OUR STRATEGY PRODUCT PORTFOLIO OUR COMPANY PRESS RELEASES CAREERS CONTACT News alert signup Stay updated on the latest developments at Hyloris. NEWS VIA EMAIL 2021 - Hyloris Pharmaceuticals SA - Design & Development by CLICK GDPR - Privacy Policy GDPR - Cookies Policy Terms of website use We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All